Verona Pharma receives FDA approval for first inhaled COPD treatment
Verona Pharma announced it has received FDA approval for Ohtuvayre (Ensifentrine), a maintenance treatment for chronic obstructive pulmonary disease (COPD) in adult patients. It is the first inhaled product available for the disease and is delivered …